Tag:
Pillar5
Latest Headlines
Latest Headlines
Ex-Pfizer facility has successful pre-approval inspection
CMO Pillar5, selected by IntelGenx to manufacture its high-strength CPI-300 bupropion hydrochloride antidepressant, has passed its FDA pre-approval inspection with no Form 483 being issued. The
